Data Foundry

Medical device recalls 2014

Boston Scientific COGNIS CRT-D — Class II medical device recall Z-0087-2015

Terminated recall by Boston Scientific CRM Corp, reported 2014-10-29, distributed nationwide. Boston Scientific identified a subset of COGNISTM CRT-Ds and TELIGENTM ICDs that had experienced an increased

Recall numberZ-0087-2015
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmBoston Scientific CRM Corp, Saint Paul, MN, United States
Recall initiated2014-09-17
Classified2014-10-17
Reported by FDA2014-10-29
Terminated2015-02-20
DistributedNationwide (US)
Countries outside the USAE, AR, AT, AU, AW, BB, BE, BM, BR, BS, CA, CH, CL, CO, CR, CY, CZ, DE, DK, DO, EC, EG, ES, FI, FR, GB, GR, HK, HN, HT, HU, ID, IE, IL, IN, IR, IT, JM, JO, JP, KR, KW, KY, LB, LK, LU, LV, MX, MY, NL, NO, NZ, PA, PE, PH, PL, PT, QA, RU, SA, SE, SG, SI, SK, SV, TH, TN, TR, TT, TW, UY, VE, ZA
Quantity31,144 total
Serial numbers001589, 001590, 001591, 001592, 001594, 001596, 001597, 001598, 001599, 001600, 001601, 001602, 001603, 001605, 001606, 001607, 001608, 001609, 001610, 001611, 001612, 001613, 001615, 001616, 001617 and 475 more
Model numbersN106, N107, N108, N118, N119, P106, P107, P108

Product

Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.

Reason for recall

Boston Scientific identified a subset of COGNISTM CRT-Ds and TELIGENTM ICDs that had experienced an increased rate of premature battery depletion due to compromised performance of a low voltage (LV) capacitor. Boston Scientific updated their August 2013 Physician communication to include additional devices that may experience premature battery depletion due to compromised performance of a low volt

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0087-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.